EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Molecular Designs, a developer and manufacturer of molecular infectious disease assays, today announced it has submitted a ...
NEW YORK, Aug. 12 (UPI) --Blood and urine tests are ineffective for diagnosing long COVID -- a constellation of long-term symptoms such as chronic pain, brain fog, shortness of breath and intense ...
Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of innovative in vitro diagnostic technologies, is ...
Medicare Part B covers COVID-19 tests when conducted in laboratories. Part A may cover lab tests if needed in hospital or skilled nursing facility settings. Since 2023, Medicare has no longer covered ...
Researchers have introduced a molecular switch that could control when drugs are active or inactive in the body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback